|
|
|
This week on Business of Biotech, Annette Bakker and Andrew Lo examine how abandoned drug candidates can be transformed into viable therapies through innovation and finance. |
|
|
|
|
|
|
|
|
| Subject Matter Experts Matter In Decision-Making | Expert-led ontology and taxonomy practices help organize data into meaningful hierarchies, making it easier to connect diseases, drug targets, and strategic insights that support stronger decisions. |
|
|
|
|
| Connect With Life Science Leader: |
|
|
|